Analytical method development and validation for the simultaneous estimation of Paracetamol and Tapentadol by RP-HPLC in bulk and pharmaceutical dosage forms

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 6

Abstract

A simple rapid, accurate, precise and reproducible validated reverse phase HPLC method was developed for the determination of Paracetamol and Tapentadol in bulk and pharmaceutical dosage forms. The quantification was carried out using Thermo hypersil BDS C18 (100 X 4.6 mm, 5 µm) column run in isocratic way using mobile phase comprising of Ammonium acetate buffer and methanol in the ratio of 50:50 w/v by adjusting the pH to 6.5(±0.5) with orthophosphoric acid and a detection wavelength of 280nm, and injection volume of 10µL, with a flow rate of 1.0ml/min. The retention times of Paracetamol and Tapentadol was found to be 1.362 and 2.273. The linearity ranges of the proposed method lies between 0.50 mg/mL to 0.150 mg/mL, which is equivalent to 50% to 150% and with correlation coefficient of r2=1.0 and 0.999 for Paracetamol and Tapentadol . The assay of the proposed method was found to be 101.0% and 98.0%. The recovery studies were also carried out and mean % Recovery was and found to be 99.0% to 99.0%. LOD values for Paracetamol and Tapentadol was found to be 0.22 and 0.64 respectively and LOQ were found to be 0.68 and 1.96 respectively. The % RSD from reproducibility was found to be <2%. The proposed method was statistically evaluated and can be applied for routine quality control analysis of Paracetamol and Tapentadol in bulk and in Pharmaceutical dosage form.

Authors and Affiliations

V. Praveen Kumar Reddy, Aneesha, D. Sindhura, M. Sravani, Thandava Krishna Reddy

Keywords

Related Articles

Formulation & evaluation of aripiprazole solid lipid nanoparticles for brain targeting

The objective of this research work was to formulate Aripiprazole solid lipid nanoparticles for brain targeting by surpassing the Blood brain barrier (BBB) and increasing the retention time in the brain for better ther...

Design and characterization of nanoparticulate drug delivery system of an anticancer drug: Imatinib mesylate

The present study was aimed to develop a nanoparticulate drug delivery system of Imatinib mesylate using a biodegradable polymer such as poly lactic acid (PLA). The design of Imatinib mesylate nanoparticles is proposed...

Design and development of Metformin hydrochloride Trilayered sustained release tablets

Diabetes is one of the major causes of death and disability in the world. Diabetes results from decreased secretion of insulin, decreased insulin action or both. The main aims of the investigation was to design and dev...

FORMULATION AND EVALUATION OF CEFPODOXIME PROXETIL SUSTAINED RELEASE MATRIX TABLETS

Formulation of Cefpodoxime proxetil extended release matrix tablets. The aim of the present study is to develop a pharmaceutically stable, once a day robust formulation which will have similar clinical efficacy as that...

A STUDY ON ROLE OF DEMOGRAPHIC FACTORS IN SMALL INVESTORS’ SAVINGS IN STOCK MARKET

Stock market helps to channelize household savings to the corporate sector which in turn utilize for the development of industrial and service sector. An equity share is a part of the ownership capital of a company and...

Download PDF file
  • EP ID EP33158
  • DOI -
  • Views 281
  • Downloads 0

How To Cite

V. Praveen Kumar Reddy, Aneesha, D. Sindhura, M. Sravani, Thandava Krishna Reddy (2013). Analytical method development and validation for the simultaneous estimation of Paracetamol and Tapentadol by RP-HPLC in bulk and pharmaceutical dosage forms. Indian Journal of Research in Pharmacy and Biotechnology, 1(6), -. https://europub.co.uk/articles/-A-33158